Prevalence of debrisoquine oxidation phenotypes in glaucoma patients

[1]  M. Lennard.  Oxidation phenotype and the metabolism and action of beta-blockers , 1985, Klinische Wochenschrift.

[2]  R. Huupponen,et al.  Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. , 1988, British journal of clinical pharmacology.

[3]  A. Boobis,et al.  Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine. , 1986, British journal of clinical pharmacology.

[4]  R. Lindberg,et al.  Inhibitory effects of neuroleptics on debrisoquine oxidation in man. , 1986, British journal of clinical pharmacology.

[5]  G. Tucker,et al.  The Polymorphic Oxidation of β-Adrenoceptor Antagonists , 1986 .

[6]  R. Huupponen,et al.  Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. , 1986, Journal of ocular pharmacology.

[7]  J. J. Fleming,et al.  Pharmacokinetics and beta‐blocking effects of timolol in poor and extensive metabolizers of debrisoquin , 1985, Clinical pharmacology and therapeutics.

[8]  G. Tucker,et al.  Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics. , 1985, British journal of clinical pharmacology.

[9]  R. Huupponen,et al.  Systemic absorption of topically applied ocular timolol. , 1985, Journal of ocular pharmacology.

[10]  E. V. Van Buskirk,et al.  Ocular beta-blockers and systemic effects. , 1986, American journal of ophthalmology.

[11]  M. Eichelbaum.  Polymorphic drug oxidation in humans. , 1984, Federation proceedings.

[12]  H. Shichi.  Biotransformation and Drug Metabolism , 1984 .

[13]  S. Drance,et al.  Glaucoma, applied pharmacology in medical treatment , 1984 .

[14]  G. Alván,et al.  HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATION , 1982, The Lancet.

[15]  J. Idle,et al.  A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. , 1980, Journal of medical genetics.

[16]  G. Tucker,et al.  POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE , 1977, The Lancet.

[17]  G. Tucker,et al.  Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. , 1977, Journal of chromatography.

[18]  McLellan Gh.  Letter: SI units. , 1975 .

[19]  D. Tocco,et al.  Physiological disposition and metabolism of timolol in man and laboratory animals. , 1975, Drug metabolism and disposition: the biological fate of chemicals.